Weight control drugs on hot market competition

Leading Korean companies, including Ilsung Pharm and Chong Kun Dang Pharm, have recently launched weight control drugs, which were formulated with a modified or generic ingredient that had kept enjoying its weight control market as a front runner, thus, shedding a red light on its competitive market.

The 60 billion won of the sibutramine markets so far enjoyed by two companies may be encount...